Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study. [PDF]
Vanderkerken M +9 more
europepmc +1 more source
High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. [PDF]
Gutierrez CLD +3 more
europepmc +1 more source
When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia. [PDF]
Benrashid S, Woyach JA.
europepmc +1 more source
Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus. [PDF]
D'Amato M +17 more
europepmc +1 more source
Unusual Nasopharyngeal Localization of Chronic Lymphocytic Leukemia: A Case Report. [PDF]
Fadi M +4 more
europepmc +1 more source
Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis. [PDF]
Hetta HF +14 more
europepmc +1 more source
Non-ST-Segment Elevation Myocardial Infarction as the Initial Presentation of Chronic Lymphocytic Leukemia. [PDF]
Gitte PT, Kharche M, Khedkar U.
europepmc +1 more source
Dueling Malignancies: A Rare Case of Concurrent Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML) in a Multimorbid Elderly Patient. [PDF]
Alzahim M +5 more
europepmc +1 more source

